Studies focused on aerobic glycolysis (AG), i.e. the catabolism of glucose without OXPHOS, and Tau pathology have revealed that loss in AG, related to aging, induces a decrease in synaptic plasticity and neuroprotection, facilitating the aggregation of Tau in individuals with amyloid burden. This evidence concerns the gene MAPT and amyloidosis.